Atlantic Technology, University of Innsbruck deal

ATLC licensed from the university rights to ATV-02, a broad spectrum antimicrobial agent in Phase II testing for viral and bacterial conjunctivitis as well as acute and chronic sinusitis. ATLC said AT...